S016 Business and Leadership: What Dermatologists Should Know
DESCRIPTION
Medicine is one of the largest Businesses in the world. Most medical training does not involve learning about this important topic. In this session, Dermatologists and trainees will learn about various aspects of Business and Leadership in Medicine and Dermatology.
LEARNING OBJECTIVES
Summarize various business aspects of Dermatology and Medicine
Outline various practice settings for Dermatologists and Trainees
Recognize leadership perspectives in AAD and AMA
SCHEDULE
1:00 PM
How to run a successful Dermatology organization
Mark D. Kaufmann, MD, FAAD
1:15 PM
Business of Dermatology and Medicine
Keyvan Nouri, MBA, MD, FAAD
1:45 PM
Coding and billing in Medical Dermatology
Dirk Michael Elston, MD, FAAD
2:00 PM
Coding and billing in Surgical Dermatology
Howard Wooding Rogers, MD, PhD, FAAD
2:15 PM
How to run a successful Medical Dermatology Practice
Amy J McMichael, MD, FAAD
2:30 PM
How to run a successful Surgical/Cosmetic Dermatology Practice
Roy G. Geronemus, MD, FAAD
2:45 PM
How to run a successful Dermatopathology practice
Tammie C. Ferringer, MD, FAAD
3:00 PM
How to run a successful Pediatric Dermatology practice
Robert Sidbury, MD, MPH, FAAD
3:15 PM
Physician Leadership: Perspectives from the AMA President
Jack S. Resneck Jr., MD, FAAD
3:30 PM
How to get more involved in AAD Leadership
Marta Jane Van Beek, MD, MPH, FAAD
3:45 PM
Q&A
DIRECTOR
Keyvan Nouri, MBA, MD, FAAD
SPEAKERS
Dirk Michael Elston, MD, FAAD
Tammie C. Ferringer, MD, FAAD
Roy G. Geronemus, MD, FAAD
Mark D. Kaufmann, MD, FAAD
Amy J McMichael, MD, FAAD
Jack S. Resneck Jr., MD, FAAD
Howard Wooding Rogers, MD, PhD, FAAD
Robert Sidbury, MD, MPH, FAAD
Marta Jane Van Beek, MD, MPH, FAAD
HANDOUTS
DISCLOSURES
Dirk Michael Elston, MD, FAAD
No financial relationships exist with ineligible companies.
Tammie C. Ferringer, MD, FAAD
No financial relationships exist with ineligible companies.
Roy G. Geronemus, MD, FAAD
Accure, Inc – Stockholder Private Company(No Compensation Received); AVAVA, Inc. – Investigator(No Compensation Received); Sciton Inc. – Investigator(No Compensation Received);
Mark D. Kaufmann, MD, FAAD
Almirall – Consultant (1099 relationship)(Fees); Apogee Therapeutics – Consultant (1099 relationship)(Fees); Biofrontera – Consultant (1099 relationship)(Fees); Botanix Pharmaceuticals – Advisory Board(Fees); CryoCaptures LLC – Stockholder Private Company(Stock); Dermsquared – Stockholder Private Company(Stock); DermTech Inc. – Consultant (1099 relationship)(Fees); Feldan Therapeutics – Consultant (1099 relationship)(Fees); Genius Clinic, Inc – Stockholder Private Company(Stock Options); Incyte – Consultant (1099 relationship)(Fees); Novartis – Consultant (1099 relationship)(Fees); NuVida – Advisory Board(Fees); Oruka Therapeutics – Consultant (1099 relationship)(Fees); Peerwise Medical Corp – Stockholder Private Company(Stock); Pelthos Therapeutics – Consultant (1099 relationship)(Fees); Sanofi/Regeneron – Consultant (1099 relationship)(Fees); SciBASE – Consultant (1099 relationship)(Fees); Sun Pharmaceutical Industries Ltd. – Consultant (1099 relationship)(Fees); UCB Pharma – Consultant (1099 relationship)(Fees); VeraDermics Inc. – Advisory Board(Fees); Verrica Pharmaceuticals Inc – Consultant (1099 relationship)(Fees); Xtresse – Stockholder Private Company(Stock);
Amy J McMichael, MD, FAAD
Aclaris Therapeutics Inc. – Consultant(Honoraria), Investigator(Grants/Research Funding); Allergan, Inc. – Consultant(Honoraria); Apogee BioPharm – Advisory Board(No Compensation Received); Arcutis Biotherapeutics – Advisory Board(Honoraria); Bristol-Myers Squibb – Advisory Board(Honoraria); Canfield Scientific, Inc. – Consultant (1099 relationship)(Honoraria); Cassiopea S.p.A. – Investigator(Grants/Research Funding); CeraVe/Valeante – Consultant(Honoraria); Concert Pharmaceuticals – Investigator(Grants/Research Funding); Eli Lilly and Company – Consultant (1099 relationship)(Honoraria); Elsevier Inc. – Other(Patent royalties or other compensation for Intellectual Property Rights); Galderma Laboratories, L.P. – Consultant(Other Financial Benefit); Incyte Corporation – Consultant(Honoraria), Investigator(Grants/Research Funding); Informa – Other(Other Financial Benefit); JAMA – Other(No Compensation Received); Janssen Pharmaceuticals, Inc – Consultant(Honoraria); Johnson & Johnson Consumer Products Company – Consultant(Honoraria); Kenvue – Consultant (1099 relationship)(Honoraria); L'Oreal USA Inc. – Advisory Board(Honoraria); LearnHealth/LearnSkin – Speaker/Faculty Education(Honoraria); Leo Pharma – Consultant (1099 relationship)(Honoraria); McGraw-Hill Companies – Other(Patent royalties or other compensation for Intellectual Property Rights); NAAF – Advisory Board(No Compensation Received); North American Hair Research Society – Board of Directors(No Compensation Received); Nutrafol – Advisory Board(Honoraria); Pelage Pharmaceuticals – Consultant (1099 relationship)(Honoraria); Pfizer Inc. – Consultant(Honoraria), Consultant(Other Financial Benefit); Procter & Gamble Company – Consultant(Honoraria), Investigator(Other Financial Benefit); Revian LTD. – Board of Directors(Honoraria); Sanofi/Regeneron – Advisory Board(Honoraria); Sun Pharmaceutical Industries Ltd. – Consultant (1099 relationship)(Honoraria); UCB – Consultant(Honoraria); UpToDate, Inc – Speaker/Faculty Education(Honoraria); VeraDermics Inc. – Consultant (1099 relationship)(Honoraria);
Keyvan Nouri, MBA, MD, FAAD
iVeena Delivery Systems-Eye Drug Delivery – Stockholder(No Compensation Received); Pfizer Inc. – Stockholder(No Compensation Received);
Jack S. Resneck Jr., MD, FAAD
No financial relationships exist with ineligible companies.
Howard Wooding Rogers, MD, PhD, FAAD
Biofrontera AG – Consultant (1099 relationship)(Fees);
Robert Sidbury, MD, MPH, FAAD
Alphyn Biologics – Consultant (1099 relationship)(Fees); Arcutis, Inc. – Advisory Board(Honoraria); Dermavent – Advisory Board(Honoraria); Eli Lilly – Advisory Board(Honoraria); Galderma Global – Consultant(Honoraria); Leo Pharma Inc – Advisory Board(Honoraria); Regeneron Pharmaceuticals, Inc. – Investigator(No Compensation Received);
Marta Jane Van Beek, MD, MPH, FAAD
No financial relationships exist with ineligible companies.